3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
2
Status
Recruiting
2
Sponsor Class
OTHER
2
Study Type
Interventional
2
Sponsor
Cancer Type
Gastrointestinal
2
Conditions
Colorectal Neoplasms
18
Carcinoma, Non-Small-Cell Lung
14
Breast Neoplasms
14
Lung Neoplasms
12
Head and Neck Neoplasms
10
Rectal Neoplasms
8
Prostatic Neoplasms
7
Mouth Neoplasms
5
Glioblastoma
5
Esophageal Neoplasms
5
Colonic Neoplasms
5
Central Nervous System Neoplasms
5
Pancreatic Neoplasms
4
Oropharyngeal Neoplasms
4
Neoplasm Metastasis
4
Hypopharyngeal Neoplasms
4
Gliosarcoma
4
Carcinoma
4
Squamous Cell Carcinoma of Head and Neck
3
Sarcoma
3
Ovarian Neoplasms
3
Neuroblastoma
3
Neoplasms
3
Laryngeal Neoplasms
3
Brain Neoplasms
3
Uterine Cervical Dysplasia
2
Turcot syndrome
2
Tongue Neoplasms
2
Salivary Gland Neoplasms
2
Recurrence
2
Interventions
Nivolumab
5
pembrolizumab
3
avelumab
3
Neoadjuvant Therapy
3
toripalimab
2
durvalumab
2
atezolizumab
2
Celecoxib
2
spartalizumab
1
relatlimab
1
fludarabine phosphate
1
fludarabine
1
dostarlimab
1
danvatirsen
1
XELOX
1
Surgical Procedures, Operative
1
Oxaliplatin
1
Leucovorin
1
Ipilimumab
1
Induction Chemotherapy
1
Immunotherapy
1
Immunoglobulin G
1
Immune Checkpoint Inhibitors
1
IMM-101
1
Fluorouracil
1
Docetaxel
1
Disulfides
1
DEAE-Dextran
1
Cyclophosphamide
1
Chemotherapy, Adjuvant
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
Phase 2
×
Turcot syndrome
×
Celecoxib
×
Clear all
NCT06903858
2026-05-22
PICC-3
Sun Yat-sen University
Phase 2
Recruiting
105 enrolled
NCT03926338
2025-11-20
PICC
Sun Yat-sen University
Phase 2
Recruiting
270 enrolled